WGS FY 2024 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena

WGSGeneDx Holdings Corp.

$3B

FY 2024 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$305M+50.8% YoY

Gross Profit

$194M63.6% margin

Operating Income

-$23M-7.6% margin

Net Income

-$52M-17.1% margin

EPS (Diluted)

$-1.94

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$34M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$419M

Total Liabilities

$174M

Stockholders' Equity

$245M

Cash & Equivalents

$85M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$305M	$203M	+50.8%
Gross Profit	$194M	$90M	+116.0%
Operating Income	-$23M	-$181M	+87.1%
Net Income	-$52M	-$176M	+70.3%